Unité de Fabrication des Médicaments Future Growth
Future criteria checks 2/6
Unité de Fabrication des Médicaments is forecast to grow earnings and revenue by 12.8% and 8.7% per annum respectively. EPS is expected to grow by 23.4% per annum. Return on equity is forecast to be 17.1% in 3 years.
Key information
12.8%
Earnings growth rate
23.4%
EPS growth rate
Pharmaceuticals earnings growth | 18.7% |
Revenue growth rate | 8.7% |
Future return on equity | 17.1% |
Analyst coverage | Low |
Last updated | 25 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 148 | 19 | N/A | N/A | 1 |
12/31/2024 | 141 | 18 | 9 | 29 | 1 |
12/31/2023 | 134 | 17 | 1 | 26 | 1 |
6/30/2023 | 115 | 13 | -5 | 16 | N/A |
3/31/2023 | 106 | 10 | -9 | 10 | N/A |
12/31/2022 | 96 | 8 | -12 | 4 | N/A |
9/30/2022 | 91 | 6 | -8 | 4 | N/A |
6/30/2022 | 86 | 5 | -4 | 3 | N/A |
3/31/2022 | 85 | 7 | 5 | 12 | N/A |
12/31/2021 | 85 | 9 | 15 | 21 | N/A |
9/30/2021 | 85 | 7 | 16 | 22 | N/A |
6/30/2021 | 86 | 6 | 17 | 22 | N/A |
3/31/2021 | 89 | 7 | 9 | 14 | N/A |
12/31/2020 | 91 | 7 | 0 | 7 | N/A |
9/30/2020 | 93 | 10 | 1 | 13 | N/A |
6/30/2020 | 95 | 12 | 2 | 18 | N/A |
3/31/2020 | 101 | 15 | -1 | 16 | N/A |
12/31/2019 | 107 | 18 | -3 | 15 | N/A |
9/30/2019 | 107 | 20 | -7 | 11 | N/A |
6/30/2019 | 107 | 22 | -10 | 8 | N/A |
3/31/2019 | 97 | 20 | -7 | 11 | N/A |
12/31/2018 | 87 | 18 | -4 | 13 | N/A |
9/30/2018 | 80 | 16 | -5 | 12 | N/A |
6/30/2018 | 73 | 13 | -5 | 11 | N/A |
3/31/2018 | 72 | 13 | -1 | 14 | N/A |
12/31/2017 | 70 | 13 | 4 | 17 | N/A |
9/30/2017 | 69 | 12 | 8 | 19 | N/A |
6/30/2017 | 68 | 11 | 11 | 20 | N/A |
3/31/2017 | 66 | 11 | N/A | 20 | N/A |
12/31/2016 | 65 | 11 | N/A | 20 | N/A |
9/30/2016 | 63 | 13 | N/A | 19 | N/A |
6/30/2016 | 61 | 15 | N/A | 18 | N/A |
3/31/2016 | 60 | 14 | N/A | 15 | N/A |
12/31/2015 | 59 | 13 | N/A | 12 | N/A |
9/30/2015 | 60 | 12 | N/A | 16 | N/A |
6/30/2015 | 60 | 11 | N/A | 19 | N/A |
3/31/2015 | 59 | 12 | N/A | 20 | N/A |
12/31/2014 | 58 | 12 | N/A | 21 | N/A |
12/31/2013 | 47 | 10 | N/A | 10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: UMED's forecast earnings growth (12.8% per year) is below the savings rate (14.3%).
Earnings vs Market: UMED's earnings (12.8% per year) are forecast to grow faster than the TN market (0.9% per year).
High Growth Earnings: UMED's earnings are forecast to grow, but not significantly.
Revenue vs Market: UMED's revenue (8.7% per year) is forecast to grow faster than the TN market (6.2% per year).
High Growth Revenue: UMED's revenue (8.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: UMED's Return on Equity is forecast to be low in 3 years time (17.1%).